Genovefa A Papanicolaou Selected Research

maribavir

9/2022	Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
1/2019	Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
4/2011	Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
6/2008	Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genovefa A Papanicolaou Research Topics

Disease

20	Infections 07/2022 - 12/2007
9	Cytomegalovirus Infections (Inclusion Disease) 09/2022 - 06/2008
7	Viremia 09/2022 - 03/2013
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 12/2007
5	Neutropenia 09/2022 - 04/2011
4	Communicable Diseases (Infectious Diseases) 12/2021 - 12/2019
4	COVID-19 11/2021 - 01/2020
4	Invasive Fungal Infections 10/2021 - 01/2010
4	Bacteremia 01/2019 - 12/2004
3	Neoplasms (Cancer) 01/2022 - 01/2018
3	Leukemia 11/2021 - 01/2018
3	Mycoses (Diseases, Fungus) 10/2021 - 01/2010
2	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 03/2016
2	Multiple Myeloma 11/2021 - 12/2019
2	Virus Diseases (Viral Diseases) 10/2021 - 01/2021
2	Adenoviridae Infections (Adenovirus Infections) 09/2021 - 08/2017
2	Hemorrhagic Cystitis 01/2021 - 08/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2019 - 01/2018
2	Diarrhea 01/2019 - 09/2013
2	Opportunistic Infections (Opportunistic Infection) 01/2018 - 12/2007
2	Herpes Zoster 01/2018 - 11/2014
2	Coinfection 10/2017 - 01/2013
2	Weight Loss (Weight Reduction) 01/2013 - 05/2010
2	Human Influenza (Influenza) 01/2013 - 05/2010
2	Disease Progression 01/2013 - 05/2010
1	Acute Kidney Injury (Acute Renal Failure) 09/2022
1	Lymphoma (Lymphomas) 11/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019
1	Sepsis (Septicemia) 10/2019
1	Dysgeusia (Parageusia) 01/2019
1	Chickenpox 01/2018
1	Breakthrough Infections 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 03/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2016
1	Pneumonia (Pneumonitis) 11/2014
1	Liver Failure 01/2010
1	Liver Diseases (Liver Disease) 12/2008
1	Nausea 06/2008
1	Vomiting 06/2008

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 06/2008
6	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2010
5	brincidofovirIBA 09/2021 - 09/2013
5	Vancomycin FDA LinkGeneric 10/2019 - 12/2004
4	Ganciclovir (Cytovene)FDA LinkGeneric 09/2022 - 06/2008
4	maribavirIBA 09/2022 - 06/2008
4	VaccinesIBA 11/2021 - 11/2014
4	Voriconazole (Vfend)FDA LinkGeneric 10/2021 - 01/2010
2	Valganciclovir FDA Link 09/2022 - 01/2015
2	Foscarnet FDA LinkGeneric 09/2022 - 01/2019
2	Cidofovir (Vistide)FDA Link 10/2021 - 01/2019
2	posaconazole FDA Link 10/2021 - 01/2018
2	isavuconazoleIBA 10/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 09/2013
2	Micafungin (FK463)FDA Link 08/2018 - 01/2018
2	Linezolid (Zyvox)FDA Link 01/2013 - 10/2009
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 05/2010
2	CytokinesIBA 01/2013 - 05/2010
1	letermovirIBA 07/2022
1	COVID-19 VaccinesIBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	liposomal amphotericin B FDA Link 10/2021
1	TriazolesIBA 01/2020
1	Chimeric Antigen ReceptorsIBA 12/2019
1	AzolesIBA 01/2018
1	Herpes Zoster VaccineIBA 01/2018
1	EchinocandinsIBA 01/2018
1	AntibodiesIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	FluoroquinolonesIBA 10/2014
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	Interleukin-12 (IL 12)IBA 01/2013
1	Polysaccharides (Glycans)IBA 05/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2008

Therapy/Procedure

17	Cell Transplantation 01/2022 - 01/2015
16	Therapeutics 09/2022 - 12/2007
9	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2004
8	Transplantation 12/2021 - 12/2007
2	Stem Cell Transplantation 12/2019 - 08/2014
2	Length of Stay 01/2019 - 12/2008
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2018
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Immunotherapy 12/2019
1	Animal Assisted Therapy 01/2019
1	Organ Transplantation 03/2016